# NSN 6505-01-476-8686: Ciprofloxacin Hydrochloride Opht

NSN 6505-01-476-8686 (also written 6505014768686; NIIN 01-476-8686) is a ciprofloxacin hydrochloride opht in Federal Supply Class 6505, Drugs and Biologicals. 3 manufacturer part numbers from 3 suppliers are on record. It was last purchased in Oct 2026.

## Identification

- NSN: 6505-01-476-8686 (6505014768686)
- NIIN: 01-476-8686 (014768686)
- Item name: CIPROFLOXACIN HYDROCHLORIDE OPHT
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC Z: a commercial, nondevelopmental or off-the-shelf item. (observed 2026-10-10)
- Acquisition method code: 3

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | GRAMS CIPROFLOXACIN HYDROCHLORIDE ACTIVE INGREDIENT 3.330 |
| CBBL | FEATURES PROVIDED | STERILE |
| CQCT | PRIMARY CONTAINER TYPE | TUBE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | GRAMS 3.500 |
| CSGS | ADMINISTRATION | OPHTHALMIC |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC OINTMENT 3.5GM TUBE |
| FEAT | SPECIAL FEATURES | EACH GRAM OF CILOXAN OINTMENT CONTAINS CIPROFLOXACIN HCL 3.33 MG EQUIVALENT TO 3 MG BASE; CILOXAN OPHTHALMIC OINTMENT IS A SYNTHETIC, STERILE, MULTIPLE DOSE ANTIMICROBIAL FOR TOPICAL USE, NOT FOR INJECTION INTO THE EYE;INDICATED FOR THE TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF MICROORGANISMS(AEROBIC GRAM POSITIVE AND AEROBIC GRAM NEGATIVE); STORE AT 2 TO 25 DEG C |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| 00-0455 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC00065-0654-35 | 4LQT5 | VETERANS HEALTH | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC0007-0841-01 | 04520 | NOVARTIS PHARMACEUTICALS CORPORATION | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-10-13 | [SPE2DX25D9900/SPE2DP27F0185](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC O | DMS PHARMACEUTICAL GROUP INC | $504.09 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0043](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0044](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0045](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0050](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0052](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0053](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0056](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0057](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686) | CIPROFLOXACIN HYDRO | DMS PHARMACEUTICAL GROUP INC | $168.03 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505014768686&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505014768686
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-01-476-8686/
JSON: https://nsnexplorer.com/api/nsn/6505-01-476-8686.json